Zacks Research Has Negative Forecast for SBC Q3 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Analysts at Zacks Research decreased their Q3 2026 EPS estimates for SBC Medical Group in a research note issued on Wednesday, August 19th. Zacks Research analyst M. Marin now expects that the company will post earnings of $0.10 per share for the quarter, down from their previous estimate of $0.13. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.48 per share. Zacks Research also issued estimates for SBC Medical Group’s Q4 2026 earnings at $0.10 EPS.

SBC Medical Group (NASDAQ:SBC) last released its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The firm had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million.

Other research analysts have also issued reports about the stock. Weiss Ratings lowered shares of SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, May 22nd. BTIG Research reiterated a “buy” rating and set a $8.00 price objective on shares of SBC Medical Group in a research report on Thursday, August 13th. Finally, Wall Street Zen raised shares of SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 15th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $8.50.

SBC Medical Group Stock Up 7.5%

SBC opened at $3.87 on Thursday. The firm has a 50-day simple moving average of $3.12 and a two-hundred day simple moving average of $3.55. SBC Medical Group has a 52 week low of $2.78 and a 52 week high of $5.07. The company has a market capitalization of $396.98 million, a PE ratio of 8.23 and a beta of 0.59. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE acquired a new stake in SBC Medical Group during the second quarter worth about $35,000. Bank of New York Mellon Corp purchased a new position in SBC Medical Group during the first quarter valued at $43,000. Goldman Sachs Group Inc. acquired a new stake in shares of SBC Medical Group in the fourth quarter valued at about $49,000. Russell Investments Group Ltd. increased its stake in shares of SBC Medical Group by 292.0% during the fourth quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after purchasing an additional 8,771 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in shares of SBC Medical Group during the fourth quarter worth about $53,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.

Key SBC Medical Group News

Here are the key news stories impacting SBC Medical Group this week:

• Positive Sentiment: An analysis of SBC’s second-quarter 2026 results characterized the period as evidence of resumed growth, while the company continues implementing measures intended to support further expansion. This reinforces the recovery narrative for investors. SBC: 2Q26 results illustrate resumed growth, as growth measures continue
• Positive Sentiment: Sidoti raised its SBC earnings-per-share forecast for fiscal 2026 to $0.47 from $0.44, matching the broader consensus estimate. The firm also increased its fiscal 2027 forecast to $0.52 from $0.49, suggesting greater confidence in the company’s forward earnings trajectory. Sidoti raises SBC earnings estimates
• Positive Sentiment: Sidoti lifted its quarterly estimates for SBC, including Q3 and Q4 2026 EPS to $0.12 from $0.11, Q1 2027 EPS to $0.12 from $0.11, and Q2 2027 EPS to $0.13 from $0.12. These revisions indicate expectations for steady profitability through the next several quarters. Sidoti quarterly earnings estimate revisions
• Neutral Sentiment: A separate article contrasts SBC Medical Group with Henry Schein, but the headline does not identify a specific change to SBC’s earnings outlook, operations, or valuation. Consequently, it is unlikely to be a major standalone driver of the stock’s recent move. Contrasting Henry Schein and SBC Medical Group

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.